Merck & Co., Inc. is 193.4x more valuable than ANAPTYSBIO, INC by market capitalization ($293.16 B vs $1.52 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ANAB | MRK |
|---|---|---|
| Market cap | $1.52 B | $293.16 B |
| US-listed rank | #2310 | #44 |
| Revenue (latest FY) | $234.60M | $65.01B |
| Net income (latest FY) | -$13.23M | $18.25B |
| Net margin | -5.6% | 28.1% |
| P/E (trailing FY) | - | 16.1 |
| SEC filings | 681 | 996 |
Merck & Co., Inc. is 193.4x more valuable than ANAPTYSBIO, INC by market capitalization ($293.16 B vs $1.52 B).
In their latest fiscal years, ANAPTYSBIO, INC reported $234.60M in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: ANAPTYSBIO, INC and Merck & Co., Inc., or browse the full rankings.